New Experimental Drug Protects Nerve Cells From ALS Damage
University of Arizona researchers have developed an experimental drug, XL20, that shows potential to protect nerve cells from damage associated with amyotrophic lateral sclerosis (ALS). According to a study published in Nature Aging, the drug targets a specific region of the TDP-43 protein to prevent toxic clumping, a process that contributes to neurodegeneration in ALS … Read more